advancing generic drug development: translating science to approval 2024 – day 1 – part 3
Published 23 hours ago • 29 plays • Length 1:17:23Download video MP4
Download video MP3
Similar videos
-
7:12:31
advancing generic drug development: translating science to approval 2024 (day 1)
-
1:28:11
advancing generic drug development: translating science to approval 2023 – day 1 – part 3
-
1:23:36
advancing generic drug development: translating science to approval 2023 – day 1 – part 1
-
1:43:45
advancing generic drug development: translating science to approval – day 1 – session 3
-
6:07
advancing generic drug development: translating science to approval, day one closing remarks
-
1:15:00
advancing generic drug development: translating science to approval 2023 – day 2 – part 3
-
1:33:53
advancing generic drug development: translating science to approval 2024 – day 1 – part 1
-
2:28:46
advancing generic drug development: translating science to approval – day 1 – session 2
-
1:12:08
advancing generic drug development: translating science to approval 2024 – day 1 – part 2
-
1:01:38
advancing generic drug development: translating science to approval 2024 – day 1 – part 4
-
1:54:43
advancing generic drug development translating science to approval day 1–session 4 & closing remarks
-
6:06
advancing generic drug development: translating science to approval, day two closing remarks
-
8:05:24
advancing generic drugs development: translating science to approval 2023 - day 1
-
1:31:24
advancing generic drug development: translating science to approval 2023 – day 2 – part 2
-
1:44:40
advancing generic drug development: translating science to approval - day 1 – keynote and session 1
-
1:38:58
advancing generic drug development: translating science to approval 2023 – day 2 – part 1
-
1:45:11
advancing generic drug development: translating science to approval – day 2 – session 6
-
9:06
advancing generic drug development: translating science to approval keynote address
-
7:01:55
advancing generic drug development: translating science to approval 2024 (day 2)